Stem Cell Therapy for Early Alzheimer's Disease
NCT06775964
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participants, so they are their own donor. The main questions this trial aims to answer are: Does stem cell therapy reduce inflammation in the brain? Does stem cell therapy improve brain activity? Does stem cell therapy slow down progression to Alzheimer's disease?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cognitive Dysfunction
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 60 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Paul E Schulz
- Last updated on ClinicalTrials.gov
- April 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Texas · 1
- The University of Texas Health Science Center at Houston (UTHealth) · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.